Hanmi to launch first Amlodipine generic soon in Korea.

Published: 2004-06-11 06:58:00

Updated: 2004-06-11 06:58:00

Hanmi announced on June 9 the approval of Amodipine sale, a new amlodipine modified drug, as the first amlodipine generic in Korea, giving a critical challenge to Norvasc (Pfizer Korea), the top prescription drug in Korea with 150 billion won of sales in 2003 and 30% of the total 500 billion won ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK